Cargando…
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis
INTRODUCTION: We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due to its potential to repair damaged lung tissue and boost immune responses. We aimed to assess the effectiveness of MSC to impr...
Autores principales: | Skrahin, Aliaksandr, Jenkins, Helen E., Hurevich, Henadz, Solodovnikova, Varvara, Isaikina, Yanina, Klimuk, Dzmitri, Rohava, Zoya, Skrahina, Alena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894747/ https://www.ncbi.nlm.nih.gov/pubmed/27284577 http://dx.doi.org/10.1016/j.jctube.2016.05.003 |
Ejemplares similares
-
Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory
por: Podlekareva, Daria N., et al.
Publicado: (2021) -
Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for COVID-19 in Belarus: Mixed-Methods Study
por: Sereda, Yuliia, et al.
Publicado: (2022) -
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
por: Skrahina, Alena, et al.
Publicado: (2012) -
Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience
por: Sinkou, Heorhi, et al.
Publicado: (2017) -
Safety of prolonged treatment with bedaquiline in programmatic conditions
por: Zhurkin, Dzmitriy, et al.
Publicado: (2022)